Pharmacovigilance compliance is necessary for pharmaceutical companies, biotechnology companies, and life sciences firms involved in the monitoring of the safety of drugs. Efficient pharmacovigilance makes it possible for organizations to recognize, evaluate, record, and report on any adverse events that may arise while ensuring that regulatory compliance is met in the process.
On the other hand, achieving compliance can be quite difficult. This is because of the large amount of safety data, varying regulations, tight deadlines, scattered data, and complicated global guidelines that are required. The positive thing is that the above mentioned problems can be solved.
What Is Pharmacovigilance Compliance?
Pharmacovigilance compliance means that an organization adheres to the relevant regulation regarding the detection, assessment, management, documentation, and reporting of safety information for medicines.
The Good Pharmacovigilance Practices (GVP) guideline sets out the main pharmacovigilance activities such as individual case safety report, signal management, periodic safety reporting, safety communication, and risk minimization.
In the case of companies which operate in more than one country, compliance becomes difficult because there could be different requirements, reporting mechanisms, deadlines, and health authoritiesā expectations for each market.
Common Pharmacovigilance Compliance Challenges
1. Managing High Volumes of Safety Data
The adverse event information may be obtained from spontaneous reporting systems, clinical trials, scientific literature, healthcare practitioners, patients, affiliates, websites, and other sources. It becomes increasingly hard to process such information effectively when the number of cases grows.
Solutions: Develop standardized case intakes, triages, validations, medical reviews, coding, follow-ups, and submissions process. The management of ICSRs can also aid in keeping the organization consistent and comply with regulations. Pharma Wizard, for instance, manages ICSRs for case processing, narrative writing, medical review, MedDRA coding, submissions, follow-ups, and reconciliations.
2. Keeping Up With Changing Regulations
There are still ongoing developments in pharmacovigilance regulations and guidelines. It is therefore important for organizations to keep abreast of regulatory changes and comprehend the implications of new requirements on their current safety processes.
Solution: Apply continuous pharmacovigilance regulatory intelligence. Review relevant health authorities’ guidelines and SOPs, identify regulatory change impacts and compliance gaps. The EMA’s GVP model is constantly updated, and the most recent updates include ICH E2D(R1) and ICH M14.
3. Meeting ICSR Reporting Timelines
Late and/or inaccurate safety reports of individual cases pose compliance risks. Delays may arise owing to inadequate information, inefficiencies in process flow, manual processing, and ineffective case tracking.
Solution: Clearly-defined time frames, automated reminders, quality assurance, escalation procedures, and safety databases should be used. Reconciliation and quality assurance could help identify cases at risk of delays in reporting.
4. Maintaining Data Quality and Consistency
Lack of completeness of data, lack of consistency in coding, duplication of cases, incorrect narrative and poor documentation will compromise safety data.
Suggestion for improvement: Create effective pharmacovigilance quality management system with standard operating procedures, proper training, and quality control, reconciliation and CAPA procedures.
5. Preparing for Pharmacovigilance Audits and Inspections
Inspection by regulatory agencies may uncover deficiencies in documentation, training, case management, SOPs, vendor management, or reporting process.
Solution: Implement risk-based audits within the company and act on any issues found. An audit process should ensure identification of compliance gaps, risk assessment, taking corrective actions, and evaluating CAPAs. The Pharma Wizard service offers audit assistance for pharmacovigilance and training related to strategic, tactical, and operational audits.
How Technology and Expertise Improve Pharmacovigilance Compliance
Technology may lead to reduction in manual labor, increased traceability, improved case management, and data quality. Nevertheless, technology alone cannot ensure compliance. There is also a need for qualified personnel, process validation, standard operating procedures, regulatory intelligence, and quality assurance.
A holistic pharmacovigilance solution can integrate ICSR management, literature mining, signal detection, aggregate reporting, risk management, regulatory intelligence, and safety database solutions. This will ensure that an organization develops a more consistent and inspection-ready pharmacovigilance program.
Build a Proactive Pharmacovigilance Compliance Strategy
Pharmacovigilance compliance should not be viewed as a last minute regulatory activity. Proactive pharmacovigilance involves risk identification ahead of finding them.
Firms should always assess their safety procedures, keep track of regulations, educate employees, evaluate vendors, analyze the quality of data, perform audits and improve CAPA management. Firms that do not have enough in-house capacities could use the services of a skilled pharmacovigilance outsourcing firm.
Frequently Asked Questions About Pharmacovigilance Compliance
What is pharmacovigilance compliance?
Pharmacovigilance Compliance is the adherence to relevant regulatory requirements related to monitoring of the safety of medicines, handling adverse events, management of safety data, conducting safety assessments and submission of mandatory reporting to health authorities.
What are the most common pharmacovigilance compliance challenges?
Common challenges include high volume of safety data, evolving legislation, deadlines for ICSR reporting, quality problems with data, inconsistency, lack of training, management of vendors, and readiness for regulatory inspection.
How can companies improve pharmacovigilance compliance?
Companies can ensure adherence by adopting standardized SOPs, safety databases, regulatory intelligence, quality control, employee training, risk-based audits, CAPA management, and effective case processing procedures.
Why is ICSR management important for pharmacovigilance compliance?
ICSR management guarantees that individual safety reports are appropriately handled, evaluated, documented, medically assessed, coded, followed up on, checked for quality and submission.
Is it possible to outsource pharmacovigilance services?
It is possible. The pharmaceutical and life sciences industries have the ability to outsource some or all of their pharmacovigilance tasks to experts who offer such services.
Conclusion
Pharmacovigilance compliance goes beyond just meeting reporting deadlines and involves having proper safety information, proper case processing, regulation awareness, quality systems, professionals, and continual monitoring. Through proactive handling of some pharmacovigilance compliance issues, pharmaceutical companies will be able to minimize regulatory risks and enhance safety of patients.
For those organizations that require specific services, Pharma Wizard offers wide-ranging pharmacovigilance services such as literature monitoring, adverse event intake and case processing, medical writing, signaling management, aggregate reporting, audit support, quality assurance, QPPV services, and safety regulatory intelligence.
